Inspire Medical Systems, Inc.
HealthcareNYSE:INSP · New York Stock Exchange
+$0.26 today
Vol 0.86M · Avg 1.12M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
18.6%
avg -87.8%
ROIC
6.3%
avg -32.0%
ROA
16.0%
avg -23.9%
Analysis
ROE is currently the strongest return metric at 18.6% versus its period average of -87.8%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Timothy Herbert | Founder, Chairman, Chief Executive Officer & President | $1.71M | — | 63 | $99,834.00 | 0.35% |
Carlton W. Weatherby | Chief Strategy and Growth Officer | $935,140.00 | — | 41 | $41,679.00 | 0.14% |
Bryan K. Phillips | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary | $802,538.00 | — | 55 | $38,513.00 | 0.13% |
John C. Rondoni | Chief Product & Innovation Officer | $576,716.00 | — | 46 | $27,165.00 | 0.09% |
Matthew J. Osberg | Executive VP & CFO | — | — | 49 | $19,794.00 | 0.07% |
Andreas Henke | Executive VP International & MD | — | — | — | — | — |
Ivan Lubogo | SVP of Strategic Sales | — | — | — | — | — |
Ezgi Yagci | Vice President of Investor Relations | — | — | — | — | — |
Melissa J. Mann | Chief People Officer | — | — | 50 | $23,609.00 | 0.08% |
Jason Kelly | Chief Operations and Quality Officer | — | — | 46 | $19,948.00 | 0.07% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
8
$1.64M
Net Sentiment
$1.64M
Net selling
Most Active
Rondoni John
3 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 8 sells worth $1.64M over the last 12 months. That adds up to net selling of $1.64M. Rondoni John was the most active insider with 3 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +70.9% | +27.6% (11yr)5 analysts |
| Net Income | N/A | N/A | N/A | N/A5 analysts |
| EBIT | N/A | N/A | N/A | N/A5 analysts |
Analysis
Recent growth has been strongest in Revenue at +70.9% over three years. Forward estimates point to Revenue at +27.6% (11yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Brookdale Senior Living Inc.
NYSE:BKD
$3.21B
Integer Holdings Corporation
NYSE:ITGR
$3.09B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.40B
Premier, Inc.
PINC
$2.34B
89bio, Inc.
ETNB
$2.20B
LeMaitre Vascular, Inc.
NASDAQ:LMAT
$2.10B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
Ardent Health Partners, LLC
NYSE:ARDT
$1.34B
Artivion, Inc.
NYSE:AORT
$975.72M
Who manages INSP?
Inspire Medical Systems, Inc. (INSP) lists 10 active executives. The top listed executive is Matthew J. Osberg, Executive VP & CFO.
Are INSP insiders buying or selling?
Recent insider activity shows net selling of $24.71M.
Explore More
Continue the stock analysis
Jump to another research area for this company.